Concentrations of zolpidem and zopiclone in venous blood samples from impaired drivers compared with femoral blood from forensic autopsies

Forensic Science International

Volumn 222, Issue 1-3, 2012, Pages 118-123

  Jones, Alan Wayne ^a   Holmgren, Anita ^a  

^a DEPARTMENT OF FORENSIC GENETICS AND FORENSIC TOXICOLOGY   (Sweden)

Author keywords

Autopsy; Drug interactions; Drugs and driving; DUID; Hypnotics; Intoxication; Poisoning; Zolpidem; Zopiclone

Indexed keywords

ZOLPIDEM; ZOPICLONE;

ARTICLE; AUTOPSY; CAPILLARY CHROMATOGRAPHY; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TRAFFIC; FORENSIC SCIENCE; FORENSIC TOXICOLOGY; HUMAN; HUMAN TISSUE; INTOXICATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; VENOUS BLOOD;

EID: 84865659672     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2012.05.008     Document Type: Article

References (44)

1. Sneader W. Drug Discovery - A History 2005, John Wiley, Chichester.
2. George C.F. Pyrazolopyrimidines. Lancet 2001, 358:1623-1626.
3. Terzano M.G., Rossi M., Palomba V., Smerieri A., Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf. 2003, 26:261-282.
4. Wagner J., Wagner M.L. Non-benzodiazepines for the treatment of insomnia. Sleep Med. Rev. 2000, 4:551-581.
5. Nowell P.D., Mazumdar S., Buysse D.J., Dew M.A., Reynolds C.F., Kupfer D.J. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997, 278:2170-2177.
6. Sateia M.J., Nowell P.D. Insomnia. Lancet 2004, 364:1959-1973.
7. Greenblatt D.J., Harmatz J.S., von Moltke L.L., Ehrenberg B.L., Harrel L., Corbett K., Counihan M., Graf J.A., Darwish M., Mertzanis P., Martin P.T., Cevallos W.H., Shader R.I. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin. Pharmacol. Ther. 1998, 64:553-561.
8. Jones A.W., Holmgren A., Kugelberg F.C. Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results. Ther. Drug Monit. 2007, 29:248-260.
9. Gustavsen I., Al-Sammurraie M., Morland J., Bramness J.G. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid. Anal. Prev. 2009, 41:462-466.
10. Jones A.W., Holmgren A. Concentration distributions of the drugs most frequently identified in post-mortem femoral blood representing all causes of death. Med. Sci. Law 2009, 49:257-273.
11. de Haas S.L., Schoemaker R.C., van Gerven J.M., Hoever P., Cohen A.F., Dingemanse J. Pharmacokinetics, pharmacodynamics and the pharmacokinetic/pharmacodynamic relationship of zolpidem in healthy subjects. J. Psychopharmacol. 2010, 24:1619-1629.
12. Verster J.C., Volkerts E.R., Olivier B., Johnson W., Liddicoat L. Zolpidem and traffic safety - the importance of treatment compliance. Curr. Drug Saf. 2007, 2:220-226.
13. Cimolai N. Zopiclone: is it a pharmacologic agent for abuse?. Can. Fam. Phys. 2007, 53:2124-2129.
14. Sivertsen B., Omvik S., Pallesen S., Bjorvatn B., Havik O.E., Kvale G., Nielsen G.H., Nordhus I.H. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006, 295:2851-2858.
15. Holmgren A., Holmgren P., Kugelberg F.C., Jones A.W., Ahlner J. Predominance of illicit drugs and poly-drug use among drug-impaired drivers in sweden. Traffic Injury Prev. 2007, 8:361-367.
16. Nilsson G.H., Kugelberg F.C., Kronstrand R., Ahlner J. Stability tests of zopiclone in whole blood. Forensic Sci. Int. 2010, 200:130-135.
17. Nilsson G.H., Kugelberg F.C., Ahlner J., Kronstrand R. Influence of pre-analytical conditions on the interpretation of zopiclone concentrations in whole blood. Forensic Sci. Int. 2011, 207:35-39.
18. Schenck C.H., Mahowald M.W., Sack R.L. Assessment and management of insomnia. JAMA 2003, 289:2475-2479.
19. Silber M.H. Clinical practice. Chronic insomnia. N. Engl. J. Med. 2005, 353:803-810.
20. Sullivan E. Insomnia. Lancet 2008, 371:1497.
21. Sanger D.J. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 2004, 18(Suppl 1):9-15. (discussion 41, 43-15).
22. Harrison N.L. Mechanisms of sleep induction by GABA(A) receptor agonists. J. Clin. Psychiatry 2007, 68(Suppl 5):6-12.
23. Wallner M., Olsen R.W. Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development?. Br. J. Pharmacol. 2008, 154:288-298.
24. Barbone F., McMahon A.D., Davey P.G., Morris A.D., Reid I.C., McDevitt D.G., MacDonald T.M. Association of road-traffic accidents with benzodiazepine use. Lancet 1998, 352:1331-1336.
25. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004, 18:297-328.
26. Hajak G., Muller W.E., Wittchen H.U., Pittrow D., Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 2003, 98:1371-1378.
27. Victorri-Vigneau C., Dailly E., Veyrac G., Jolliet P. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br. J. Clin. Pharmacol. 2007, 64:198-209.
28. Kuitunen T., Mattila M.J., Seppala T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. Int. Clin. Psychopharmacol. 1990, 5(Suppl 2):115-130.
29. Orriols L., Philip P., Moore N., Castot A., Gadegbeku B., Delorme B., Mallaret M., Lagarde E. Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin. Pharmacol. Ther. 2011, 89:595-601.
30. Mets M.A., de Vries J.M., de Senerpont Domis L.M., Volkerts E.R., Olivier B., Verster J.C. Next-day effects of ramelteon (8mg), zopiclone (7.5mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep 2011, 34:1327-1334.
31. Drover D.R. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin. Pharmacokinet. 2004, 43:227-238.
32. Drover D., Lemmens H., Naidu S., Cevallos W., Darwish M., Stanski D. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem. Clin. Ther. 2000, 22:1443-1461.
33. Jones A.W., Larsson H. Distribution of diazepam and nordiazepam between plasma and whole blood and the influence of hematocrit. Ther. Drug Monit. 2004, 26:380-385.
34. Logan B.K., Couper F.J. Zolpidem and driving impairment. J. Forensic Sci. 2001, 46:105-110.
35. Levine B., Wu S.C., Smialek J.E. Zolpidem distribution in postmortem cases. J. Forensic Sci. 1999, 44:369-371.
36. Winek C.L., Wahba W.W., Janssen J.K., Rozin L., Rafizadeh V. Acute overdose of zolpidem. Forensic Sci. Int. 1996, 78:165-168.
37. Lichtenwalner M., Tully R. A fatality involving zolpidem. J. Anal. Toxicol. 1997, 21:567-569.
38. Gock S.B., Wong S.H., Nuwayhid N., Venuti S.E., Kelley P.D., Teggatz J.R., Jentzen J.M. Acute zolpidem overdose - report of two cases. J. Anal. Toxicol. 1999, 23:559-562.
39. Meeker J.E., Som C.W., Macapagal E.C., Benson P.A. Zolpidem tissue concentrations in a multiple drug related death involving Ambien. J. Anal. Toxicol. 1995, 19:531-534.
40. Bramness J.G., Arnestad M., Karinen R., Hilberg T. Fatal overdose of zopiclone in an elderly woman with bronchogenic carcinoma. J. Forensic Sci. 2001, 46:1247-1249.
41. Van Bocxlaer J., Meyer E., Clauwaert K., Lambert W., Piette M., De Leenheer A. Analysis of zopiclone (Imovane) in postmortem specimens by GC-MS and HPLC with diode-array detection. J. Anal. Toxicol. 1996, 20:52-54.
42. Boniface P.J., Russell S.G. Two cases of fatal zopiclone overdose. J. Anal. Toxicol. 1996, 20:131-133.
43. Meatherall R.C. Zopiclone fatality in a hospitalized patient. J. Forensic Sci. 1997, 42:340-343.
44. Pounder D.J., Davies J.I. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion. Forensic Sci. Int. 1994, 65:177-183.